Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
How to Find a Cancer Treatment Trial
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
Featured Clinical Trials Supported by NCI
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-4 of 4 for your search:
Cancer Type/Condition:
acute myeloid leukemia/transient myeloproliferative disorder
Stage/Subtype:
acute myeloid leukemia/transient myeloproliferative disorder
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 70
Sponsor:
Other
Protocol IDs:
PRO#1278: Flu-Bu-TBI
, NCT01366612
2.
Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 to 70
Sponsor:
Other
Protocol IDs:
15954 UCB-2011
, NCT01622556
3.
Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
31 and under
Sponsor:
Other
Protocol IDs:
RELHEM
, NCT00908167
4.
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Over 12 months to 21
Sponsor:
NCI, Other
Protocol IDs:
CDR0000680970
, COG-ADVL1011, ADVL1011, NCT01164163
Select All on Page
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Follow Us:
Twitter
YouTube
Facebook
RSS
Other Versions:
Mobile
|
Español
U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
USA.gov
NIH…Turning Discovery Into Health
®